BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 188369)

  • 1. Changes of cyclic-AMP and cycic-AMP phosphodiesterase in the progression and regression of experimental atherosclerosis.
    Numano F; Maezawa H
    Ann N Y Acad Sci; 1976; 275():311-20. PubMed ID: 188369
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of thyroxine on the contents of cyclic AMP and on the activity of cyclic AMP phosphodiesterase in hepatocytes of the rat].
    Leoni S; Spagnuolo S
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1874-8. PubMed ID: 182190
    [No Abstract]   [Full Text] [Related]  

  • 3. Juvenile hormone regulation of CYCLIC AMP and cAMP phosphodiesterase activity in Oncopeltus fasciatus.
    Everson RD; Feir D
    J Insect Physiol; 1976; 22(6):781-4. PubMed ID: 181493
    [No Abstract]   [Full Text] [Related]  

  • 4. Mediation of serum-induced changes in cyclic nucleotide levels in cultured fibroblasts by cyclic nucleotide phosphodiesterase.
    Pledger WJ; Thompson WJ; Strada SJ
    Nature; 1975 Aug; 256(5520):729-31. PubMed ID: 168501
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on cyclic adenosine 3' ,5'-monophosphate levels, Adenylate cyclase and phosphodiesterase activities in the dimorphic fungus Mucor rouxii.
    Paveto C; Epstein A; Passeron S
    Arch Biochem Biophys; 1975 Aug; 169(2):449-57. PubMed ID: 170864
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possible participation of cyclic AMP in regulating acid hydrolase activity in muscle tissue in avitaminosis E and denervation].
    Kozlov AV; Korovkin BF
    Biull Eksp Biol Med; 1976 Sep; 82(9):1068-9. PubMed ID: 186139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular cyclic AMP-phosphodiesterase accelerates differentiation in Dictyostelium discoideum.
    Alcântara F; Bazill GW
    J Gen Microbiol; 1976 Feb; 92(2):351-68. PubMed ID: 176311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microassay of cyclic nucleotides in vessel wall. II. Cyclic AMP phosphodiesterase activity.
    Numano F; Takeno K; Takano T; Watanabe Y; Nakajima M; Arita M; Maezawa H; Adachi K
    Microvasc Res; 1978 Mar; 15(2):229-37. PubMed ID: 207951
    [No Abstract]   [Full Text] [Related]  

  • 9. Basal cAMP in Hela cells is protected from phosphodiesterase and does not turn over.
    Hilz H; Kaukel E; Wiegers U; Fuhrmann U
    Biochem Biophys Res Commun; 1975 May; 64(2):519-27. PubMed ID: 167746
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
    Sobolev AS; Orekhov AN; Dhirkov IuIu; Kudriashov IuB
    Dokl Akad Nauk SSSR; 1975 Sep; 224(3):713-6. PubMed ID: 173507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of ionizing radiation on the activity of adenylate cyclase, cAMP phosphodiesterase and the level of cAMP in mouse liver].
    Sobolev AS; Orekhov AN; Chirkov IuIu; Tertov VV; Kudriashov IuB
    Dokl Akad Nauk SSSR; 1977; 232(6):1445-7. PubMed ID: 192526
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase--basic and potential clinical applications.
    Hidaka H; Endo T
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():245-59. PubMed ID: 6144253
    [No Abstract]   [Full Text] [Related]  

  • 13. Calcium and papaverine interaction with soluble cardiac phosphodiesterase.
    Carpenedo F; Gaion RM; Fassina G
    Biochem Pharmacol; 1975 Nov; 24(22):2069-73. PubMed ID: 174573
    [No Abstract]   [Full Text] [Related]  

  • 14. Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity.
    Minneman KP; Iversen LL
    Nature; 1976 Mar; 260(5546):59-61. PubMed ID: 177878
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?
    Townley RG
    J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes.
    Allende CC; Bravo R; Allende JE
    J Biol Chem; 1977 Jul; 252(13):4662-6. PubMed ID: 194890
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the growth characteristics of somatic cell hybrids and their level of camp and activities of adenylate cyclase and camp phosphodiesterase.
    Tisdale MJ; Phillips BJ
    Exp Cell Res; 1976 Apr; 99(1):63-71. PubMed ID: 177303
    [No Abstract]   [Full Text] [Related]  

  • 19. Adrenal medullary cyclic nucleotide phosphodiesterase. Subcellular distribution, partial purification and regulation of enzyme activity.
    Egrie JC; Siegel FL
    Biochim Biophys Acta; 1977 Aug; 483(2):348-66. PubMed ID: 196651
    [No Abstract]   [Full Text] [Related]  

  • 20. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones.
    Goff AK; Major PW
    FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.